Cortisol synthesis and release pathway

The "Cortisol synthesis/release pathway modulation" is not a single molecular target but rather refers to the entire biochemical and regulatory cascade responsible for the production and secretion of cortisol. This process involves multiple organs and molecules: Cortisol is synthesized in the adrenal cortex from cholesterol through a series of enzymatic steps involving cytochrome P450 enzymes such as CYP11B1 and CYP11B2[1][3]. Its release is tightly regulated by the hypothalamic-pituitary-adrenal (HPA) axis. The hypothalamus secretes corticotropin-releasing hormone (CRH), which stimulates adrenocorticotropic hormone (ACTH) release from the anterior pituitary; ACTH then acts on adrenal cortical cells to promote cortisol synthesis and secretion[2][3]. Negative feedback loops exist at both hypothalamic and pituitary levels. Pharmacological agents can modulate this pathway at various points—by inhibiting steroidogenic enzymes or blocking ACTH signaling—to treat conditions associated with excess or deficient cortisol. However, because this entry describes an entire physiological process rather than a discrete molecule, it does not fit standard definitions for a therapeutic target such as receptor, enzyme, transporter, etc.[2][3]

Other names

Corticosteroid biosynthesis pathwayGlucocorticoid synthesis pathwayHypothalamic-pituitary-adrenal (HPA) axis regulation

Inhibition of steroidogenic enzymes to reduce cortisol production (e.g., inhibition of CYP11B1 or CYP11A1 by drugs like metyrapone or ketoconazole)[1]